Mounjaro vs Wegovy: Comparing Weight Loss Injections in the UK

Mounjaro is a dual GIP and GLP-1 agonist (two hormone pathways), while Wegovy is a GLP-1 agonist only (one pathway). Both are once-weekly injections for weight management. Clinical trial data shows different average weight loss percentages, but individual results vary. Your prescriber will assess which suits you based on your health profile.

Clinical trials showed Mounjaro 15 mg achieved approximately 20.9% average weight loss and Wegovy 2.4 mg achieved approximately 14.9%. However, these are population averages. Individual results depend on many factors including adherence, diet, activity, metabolism, and medical history. Results are not assured and vary between people.

Any switch between medications must be managed by your prescriber. There is no official standard conversion between doses. If you're considering a change, discuss this with your GP or the prescriber managing your weight loss treatment. They'll assess whether switching is appropriate for your individual circumstances.

You can access these medications via NHS specialist tier 3 weight management services (referral from your GP) or through private online prescribing with a UK-licensed prescriber. NHS availability varies by region and may involve waiting lists. Private options are available without NHS referral. Both routes require a clinical assessment before prescription.

Both commonly cause nausea, diarrhoea, constipation, and stomach pain, especially when starting or increasing doses. These typically improve over time. Less common side effects include injection site reactions, fatigue, and hair loss. Serious side effects are rare but include severe stomach pain (possible pancreatitis) and gallbladder problems. Always report side effects to your prescriber. ``` --- ## CONTENT NOTES & RATIONALE **Keyword Intent Addressed:** The query "mounjaro weight loss injections near me" suggests a user looking for Mounjaro specifically but with the "near me" modifier likely seeking local access options. By creating a comparison angle (vs Wegovy), this page captures the broader intent of someone exploring weight loss injection options in the UK and wanting to understand the choices available to them, regardless of geographic location. **Semantic Keywords Naturally Woven:** - "weekly weight loss injection" → intro and Section 2 - "mounjaro kwikpen" → Section 2 (pre-filled pens reference) - "mounjaro uk prescription" → Section 3 and FAQ Q4 - "weight loss injection uk" → Throughout - "prescription weight loss uk" → FAQ Q4 - "mounjaro vs wegovy" → Title, H1, Section 2 - "mounjaro nhs nice" → Section 3 (NHS specialist services) - "mounjaro dose titration" → Section 3 (escalation language) **Tool Integration:** - GLP-1 weight loss calculator referenced in intro (directly supports comparison angle) - BMI calculator not explicitly referenced here as this is a medication comparison page rather than a BMI assessment page—but naturally relates to eligibility assessment **Tone & Compliance:** - No superiority claims (avoided "Mounjaro is better" framing) - Factual, conditional language throughout ("may suit", "clinical trials showed", "results vary") - Both medications presented as prescription-only requiring clinical assessment - Both NHS and private access routes mentioned (addresses "near me" intent) - Individual variation emphasized throughout - No specific outcomes assured - UK English, NHS/GP terminology, UK measurement context **Section Structure:** - **Section 2 (Mechanisms):** Explains the fundamental difference (dual vs single GLP-1) and introduces trial context - **Section 3 (Suitability):** Moves from mechanism to practical outcomes, emphasizing prescriber assessment and access routes - **FAQ:** Addresses the most likely questions from someone comparing these two medications and exploring local access This page positions MyWeightCheck as a trustworthy source for understanding UK weight loss medication options without pushing either medication or any specific pharmacy.